In addition, microRNAs targeting the ATG9A mRNA inhibit autophagy and constitute potential therapeutic tools in pancreatic cancer, acute kidney injury, and cardiac hypertrophy37–39. This evidence concerns the gene ATG9A and familial pancreatic carcinoma.